Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 47.42 52.60 42.96 52.65 73.40 75.34 50.00 53.85 38.39 51.33
P/S ratio 5.94 7.03 7.30 9.34 15.76 17.45 10.08 12.43 8.75 12.64
P/FCF ratio 38.49 46.70 58.79 75.78 78.94 88.83 88.38 59.64 47.28 56.88
P/Operating CF 104.73 114.35 119.12 144.69 194.85 267.19 195.77 182.09 130.12 152.94
P/B ratio 0.00 0.00 0.00 126.46 67.42 81.31 55.77 30.65 21.37 33.89
Price to Tangible BV 0.00 0.00 0.00 0.00 126.62 242.22 227.45 44.00 31.61 50.31
EV/Sales 6.06 7.10 7.52 9.72 15.95 17.67 10.28 12.49 8.83 12.71
EV/EBITDA 25.05 28.19 28.96 36.51 54.63 54.80 34.24 37.74 27.36 36.33
EV/Operating CF 31.73 37.47 41.58 50.96 66.64 75.19 63.74 50.46 37.06 46.27
EV/FCF 39.23 47.16 60.54 78.85 79.91 89.94 90.09 59.95 47.74 57.16
Quick Ratio 0.64 0.70 0.48 0.50 1.23 0.67 0.42 0.96 0.71 0.64
Current Ratio 0.90 0.97 0.85 0.94 1.82 1.25 0.89 1.57 1.31 1.23
Net Debt/EBITDA 1.89 1.59 1.53 1.42 0.66 0.68 0.65 0.20 0.26 0.18
Debt/Assets 78.66% 73.60% 65.07% 54.73% 39.59% 34.88% 28.01% 21.41% 18.75% 13.42%
Debt/Equity (11.13) (23.42) (108.34) 5.64 1.44 1.23 1.26 0.47 0.39 0.28
Asset Turnover 1.18 1.21 1.36 1.43 1.31 1.36 1.30 1.22 1.19 1.30
Operating CF/Net income 1.53 1.42 1.06 1.07 1.11 1.01 0.80 1.07 1.05 1.12
Capex/Depreciation (0.82) (0.92) (1.48) (1.76) (1.12) (1.14) (1.42) (1.16) (1.01) (0.95)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (231.05%) (324.76%) (1,195.50%) 507.40% 143.54% 112.62% 104.58% 80.74% 57.66% 66.20%
ROA 14.77% 16.22% 23.20% 25.39% 28.19% 31.48% 26.20% 28.14% 27.10% 31.89%
ROIC 31.09% 35.11% 35.41% 31.69% 37.51% 41.74% 44.39% 39.67% 36.64% 45.33%
Return on Tangible Assets 82.72% 75.94% 117.46% 87.62% 56.20% 95.52% 131.82% 67.83% 84.95% 104.65%
Average Days of Receivables 42.04 43.49 41.04 40.84 44.69 41.81 43.43 45.61 44.35 46.85
Research and Development Expense of Revenue 5.70% 5.54% 5.33% 5.53% 5.22% 5.01% 7.57% 5.22% 5.64% 5.84%
Selling, General and Administrative Expense of Revenue 29.52% 29.21% 28.57% 28.23% 27.17% 24.77% 25.26% 24.64% 26.45% 24.36%
Intangible Assets out of Total Assets 0.15 0.14 0.17 0.16 0.13 0.19 0.17 0.14 0.16 0.16
Share Based Compensation of Revenue 1.12% 1.19% 1.14% 1.63% 1.14% 1.17% 1.48% 1.63% 1.55% 1.39%
Graham Net Nets (0.08) (0.06) (0.06) (0.04) (0.01) (0.01) (0.03) (0.01) (0.01) (0.01)
Graham Number 0.00 0.00 0.00 15.18 33.71 39.91 36.47 63.95 68.47 76.94
Earnings Yield 2.11% 1.90% 2.33% 1.90% 1.36% 1.33% 2.00% 1.86% 2.60% 1.95%
Free Cash Flow Yield 2.60% 2.14% 1.70% 1.32% 1.27% 1.13% 1.13% 1.68% 2.11% 1.76%
Revenue per Share 19.79 22.43 25.48 27.95 31.72 37.74 40.27 44.07 47.26 53.51
Operating CF per Share 3.78 4.25 4.61 5.33 7.59 8.87 6.49 10.91 11.27 14.69
Capex per Share (0.72) (0.87) (1.42) (1.80) (1.26) (1.40) (1.90) (1.61) (1.59) (1.72)
Free Cash Flow per Share 3.06 3.38 3.19 3.53 6.33 7.46 4.59 9.30 9.68 12.98
Cash per Share 4.37 5.38 1.43 1.05 4.50 1.70 1.35 5.46 3.50 2.24
Shareholders Equity per Share (1.21) (0.61) (0.11) 2.07 7.41 8.10 7.28 17.87 19.34 19.96
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share (1.21) (0.61) (0.11) 2.07 7.41 8.10 7.28 17.87 19.34 19.96
Free Cash Flow 274.16 296.57 277.15 303.93 540.44 636.00 384.15 772.88 798.08 1,043.58
Working Capital (88.98) (32.58) (116.27) (45.70) 479.98 192.08 (134.33) 543.71 331.98 265.01
Capital Expenditures (64.79) (76.70) (122.94) (155.22) (107.63) (119.55) (158.84) (133.63) (130.92) (138.23)
Net Current Asset Value (793.33) (795.27) (892.41) (975.01) (599.03) (791.56) (1,036.55) (280.14) (298.23) (331.55)
EV/EBIT 30.71 33.86 33.86 42.33 62.18 60.95 38.51 41.69 30.51 40.21
Capex to Sales 0.04 0.04 0.06 0.06 0.04 0.04 0.05 0.04 0.03 0.03
Net Profit Margin 12.51% 13.36% 17.04% 17.77% 21.49% 23.17% 20.17% 23.08% 22.78% 24.62%
Price to Operating Income 30.13 33.53 32.89 40.68 61.42 60.19 37.78 41.47 30.22 40.01
Other line items
Depreciation/Fixed assets 0.22 0.22 0.19 0.16 0.17 0.18 0.17 0.16 0.18 0.19
Cash ROIC (1.24%) (0.35%) (3.34%) (5.88%) 4.83% 9.97% (7.14%) 7.75% 8.63% 19.43%
Accounts Receivable Turnover 9.04 8.97 9.16 9.29 9.01 9.19 8.76 8.53 8.37 8.39
Accounts Payable Turnover 14.20 13.72 14.24 14.70 15.48 13.91 12.04 13.32 13.51 14.64
Inventory Turnover 4.61 5.41 5.76 5.65 5.61 5.54 4.28 3.93 3.98 4.33
Average Days of Payables 27.40 28.04 26.12 25.30 23.96 31.97 29.52 27.45 27.45 24.51
Days of Inventory on Hand 72.10 68.81 65.10 68.35 67.46 74.06 98.50 94.36 91.79 83.86
Average Receivables 196.41 219.55 241.73 259.08 300.37 349.89 384.48 429.03 465.51 512.98
Average Payables 56.35 63.51 68.25 70.85 73.37 95.35 113.18 110.43 112.43 112.31
Average Inventory 173.43 161.18 168.81 184.16 202.45 239.45 318.43 374.05 381.08 379.82
Average Assets 1,502.85 1,622.06 1,625.38 1,684.91 2,063.52 2,365.88 2,591.98 3,003.35 3,276.68 3,322.10
Average Common Equity (96.10) (81.03) (31.54) 84.30 405.31 661.39 649.36 1,046.63 1,539.92 1,600.35

Fold the line items

Columns are period end dates